Re-Infused Lymphocyte Dose May Not Influence Outcomes After Upfront Stem Cell ... The Myeloma Beacon The results of a recent analysis suggest that the dosage of re-infused lymphocytes during an autologous stem cell transplant does not affect relapse or survival rates in newly diagnosed multiple myeloma patients. “These findings would seem to indicate ... |
